FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2887011607> ?p ?o ?g. }

• W2887011607 endingPage "28" @default.
• W2887011607 startingPage "28" @default.
• W2887011607 abstract "Monoclonal antibody therapeutics have proven to be successful treatment options for patients, which have various indications. Particularly in oncology, therapeutic concepts involving antibodies often rely on the so-called effector functions, such as antibody dependent cellular cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC), which are programed in the antibody Fc region. However, Fc-mediated effector mechanisms often seem to be insufficient in properly activating the immune system to act against tumor cells. Furthermore, long term treatments can lead to resistance against the applied drug, which is monospecific by nature. There is promise in using specific antibodies to overcome such issues due to their capability of recruiting and activating T-cells directly at the tumor site, for instance. During the last decade, two of these entities, which are referred to as Blinatumomab and Catumaxomab, have been approved to treat patients with acute lymphoblastic leukemia and malignant ascites. In addition, Emicizumab, which is a bispecific antibody targeting clotting factors IXa and X, was recently granted market approval by the FDA in 2017 for the treatment of hemophilia A. However, the generation of these next generation therapeutics is challenging and requires tremendous engineering efforts as two distinct paratopes need to be combined from two different heavy and light chains. This mini review summarizes technologies, which enable the generation of antibodies with dual specificities." @default.
• W2887011607 created "2018-08-22" @default.
• W2887011607 creator A5002240767 @default.
• W2887011607 creator A5050687402 @default.
• W2887011607 creator A5061836189 @default.
• W2887011607 creator A5061848625 @default.
• W2887011607 date "2018-08-01" @default.
• W2887011607 modified "2023-10-18" @default.
• W2887011607 title "Engineering IgG-Like Bispecific Antibodies—An Overview" @default.
• W2887011607 cites W1531451570 @default.
• W2887011607 cites W1611251859 @default.
• W2887011607 cites W1844577666 @default.
• W2887011607 cites W1932781508 @default.
• W2887011607 cites W1966286047 @default.
• W2887011607 cites W1968924601 @default.
• W2887011607 cites W1971572485 @default.
• W2887011607 cites W1977743020 @default.
• W2887011607 cites W1982043116 @default.
• W2887011607 cites W1989465964 @default.
• W2887011607 cites W1992423971 @default.
• W2887011607 cites W1993530117 @default.
• W2887011607 cites W1993639035 @default.
• W2887011607 cites W1995375939 @default.
• W2887011607 cites W1996768467 @default.
• W2887011607 cites W2001483547 @default.
• W2887011607 cites W2021855052 @default.
• W2887011607 cites W2033439473 @default.
• W2887011607 cites W2050557902 @default.
• W2887011607 cites W2053872195 @default.
• W2887011607 cites W2074794127 @default.
• W2887011607 cites W2090193152 @default.
• W2887011607 cites W2100410983 @default.
• W2887011607 cites W2111823261 @default.
• W2887011607 cites W2116441099 @default.
• W2887011607 cites W2127132803 @default.
• W2887011607 cites W2131958242 @default.
• W2887011607 cites W2156096200 @default.
• W2887011607 cites W2163065611 @default.
• W2887011607 cites W2164143412 @default.
• W2887011607 cites W2168356942 @default.
• W2887011607 cites W2211884070 @default.
• W2887011607 cites W2293788518 @default.
• W2887011607 cites W2311619343 @default.
• W2887011607 cites W2400928773 @default.
• W2887011607 cites W2512970891 @default.
• W2887011607 cites W2517378865 @default.
• W2887011607 cites W2542944545 @default.
• W2887011607 cites W2555391732 @default.
• W2887011607 cites W2556891461 @default.
• W2887011607 cites W2571138221 @default.
• W2887011607 cites W2571206968 @default.
• W2887011607 cites W2581030149 @default.
• W2887011607 cites W2610929033 @default.
• W2887011607 cites W2727633585 @default.
• W2887011607 cites W2738516022 @default.
• W2887011607 cites W2752678874 @default.
• W2887011607 cites W2758481846 @default.
• W2887011607 cites W2771625138 @default.
• W2887011607 cites W2775716946 @default.
• W2887011607 cites W2784605149 @default.
• W2887011607 cites W2947198550 @default.
• W2887011607 cites W4230744147 @default.
• W2887011607 doi "https://doi.org/10.3390/antib7030028" @default.
• W2887011607 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6640676" @default.
• W2887011607 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31544880" @default.
• W2887011607 hasPublicationYear "2018" @default.
• W2887011607 type Work @default.
• W2887011607 sameAs 2887011607 @default.
• W2887011607 citedByCount "30" @default.
• W2887011607 countsByYear W28870116072019 @default.
• W2887011607 countsByYear W28870116072020 @default.
• W2887011607 countsByYear W28870116072021 @default.
• W2887011607 countsByYear W28870116072022 @default.
• W2887011607 countsByYear W28870116072023 @default.
• W2887011607 crossrefType "journal-article" @default.
• W2887011607 hasAuthorship W2887011607A5002240767 @default.
• W2887011607 hasAuthorship W2887011607A5050687402 @default.
• W2887011607 hasAuthorship W2887011607A5061836189 @default.
• W2887011607 hasAuthorship W2887011607A5061848625 @default.
• W2887011607 hasBestOaLocation W28870116071 @default.
• W2887011607 hasConcept C159654299 @default.
• W2887011607 hasConcept C203014093 @default.
• W2887011607 hasConcept C2778020697 @default.
• W2887011607 hasConcept C2778957590 @default.
• W2887011607 hasConcept C3020495827 @default.
• W2887011607 hasConcept C40677261 @default.
• W2887011607 hasConcept C502942594 @default.
• W2887011607 hasConcept C51785407 @default.
• W2887011607 hasConcept C542903549 @default.
• W2887011607 hasConcept C71924100 @default.
• W2887011607 hasConceptScore W2887011607C159654299 @default.
• W2887011607 hasConceptScore W2887011607C203014093 @default.
• W2887011607 hasConceptScore W2887011607C2778020697 @default.
• W2887011607 hasConceptScore W2887011607C2778957590 @default.
• W2887011607 hasConceptScore W2887011607C3020495827 @default.
• W2887011607 hasConceptScore W2887011607C40677261 @default.
• W2887011607 hasConceptScore W2887011607C502942594 @default.
• W2887011607 hasConceptScore W2887011607C51785407 @default.

• next